LY-255582
跳至導覽
跳至搜尋
| LY-255582 | |
|---|---|
| File:LY-255,582.svg | |
| 首選IUPAC名 3-{(3R,4R)-1-[(3S)-3-Cyclohexyl-3-hydroxypropyl]-3,4-dimethylpiperidin-4-yl}phenol | |
| 識別 | |
| CAS號 | 119193-09-8 |
| PubChem | 9906198 |
| ChemSpider | 8081850 |
| SMILES |
|
| InChI |
|
| InChIKey | LVVHEFJXPXAUDD-BULFRSBZBD |
| 性質 | |
| 化學式 | C22H35NO2 |
| 摩爾質量 | 345.52 g·mol−1 |
| 若非註明,所有數據均出自標準狀態(25 ℃,100 kPa)下。 | |
LY-255582是一種含氮有機化合物,化學式為C22H35NO2,屬於苯基哌啶類化合物,可作為阿片類受體的非選擇性受體拮抗劑[1],在肥胖實驗大鼠中具有減肥作用[2]。
參考文獻[編輯]
- ↑ Dhaher R, et al. Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.. Alcohol (Fayetteville, N.Y.). Feb 2012, 46 (1): 17–27. PMC 4581853 可免費查閱. PMID 21962974. doi:10.1016/j.alcohol.2011.08.011.
- ↑ Shaw WN, et al. The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat.. International Journal of Obesity. Jun 1991, 15 (6): 387–95. PMID 1653188.